Loading clinical trials...
Loading clinical trials...
The purpose of this study is to see whether naltrexone is safe and useful in preventing alcohol relapse, as well as in decreasing craving for alcohol in people with a diagnosis of alcohol and cocaine ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Pennsylvania
Collaborators
NCT02122562 · Magnetic Resonance Imaging, Major Depression, and more
NCT06676059 · Alcoholism, Substance-Related Disorders
NCT06939088 · Alcohol Use Disorder, Alcohol Abuse/Dependence, and more
NCT02604277 · Depression, Alcoholism, and more
NCT06493773 · Liver Diseases, Alcoholic, Alcohol Use Disorder, and more
University of Pennsylvania
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions